Cindy Tahl - Apr 1, 2021 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
General Counsel and Secretary
Signature
/s/ Cindy Tahl, as Attorney-in-Fact
Stock symbol
FATE
Transactions as of
Apr 1, 2021
Transactions value $
-$840,730
Form type
4
Date filed
4/4/2022, 05:01 PM
Next filing
Jan 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Options Exercise $94.1K +19.4K +10.27% $4.84 209K Apr 1, 2022 Direct F1
transaction FATE Common Stock Options Exercise $36.5K +5.57K +2.67% $6.55 214K Apr 1, 2022 Direct F1
transaction FATE Common Stock Sale -$971K -25K -11.67% $38.85* 189K Apr 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -19.4K -70.34% $0.00 8.2K Apr 1, 2022 Common Stock 19.4K $4.84 Direct F1, F2
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -5.57K -6.57% $0.00 79.2K Apr 1, 2022 Common Stock 5.57K $6.55 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021.
F2 This option is fully vested.